14:45 — Wall Street opens sharply higher, FTSE trade keeps gains
Wall Street's open has landed broadly in line with premarket indications, with the Dow adding more than 600 points, gaining 1.17% to trade at around 52,554.84.
The S&P 500 similarly added 62 points, or 0.85%, to 7,474.72, and the Nasdaq Composite is 0.96% firmer at 25,215.75.
The VIX, the so-called volatility (of fear) index, dropped sharply to 17.75, reducing some 4.5%, confirming the risk-on tone signalled through the morning.
London kept this morning's gains, with the FTSE 100 at 10,821.3, up 0.78%.
12:30 — Wall Street set to open sharply higher as softer oil price supports equities trade
At midday, Wall Street stocks were indicated to make a strongly positive start to the week.
Premarket quotes point to the S&P 500 rising nearly 1%, whilst the Dow is seen up 1.13% and the Nasdaq 100 was expected to begin stronger still, up 1.48%.
The price of oil has remained the persistent (read repetitive) factor in the session, anchoring positivity across most of the market with the obvious exception of the oil producers themselves.
In London, the FTSE 100 remains higher, last at 10,821, up around 0.7%.
Harbour Energy (LSE:HBR) and Ithaca Energy (LSE:ITH) remain pinned among Monday's fallers both losing around 6%, tracking Brent crude's decline.
Vodafone (LSE:VOD) holds its gain at the top of the leaderboard, last at 119.4625p (+4.24%) and sitting at its session high.
Gold has firmed through the session rather than pulled back, at 4,104 per ounce (+0.83%).
Vesuvius (LSE:VSVS) remains the session's sharpest faller after its trading update flagged operational issues in its Steel division and a more challenging European market for Advanced Refractories, with trading profit for H1 2026 now expected at around £74m; the shares are down 8.32% at 414.4p.
11:50 — AstraZeneca's healthy growth sees it among Monday's top London stocks
AstraZeneca (LSE:AZN) shares was a notable mover on Monday, climbing 1.9% to 12,908p, after first-half results delivered 6% revenue growth and 11% core EPS growth at constant exchange rates, with double-digit gains in oncology and rare disease offsetting the expected Farxiga patent losses in the US.
The company described it as continued progress toward its $80bn 2030 revenue ambition, with the interim dividend lifted to $1.06 a share.
Shore Capital's Dr Sean Conroy called it a "high-quality, diversified growth story," with the shares trading around 16x FY26 forecast earnings, broadly in line with peers.
FTSE 100 holds gains
Elsewhere, the FTSE 100 is holding its morning advance, last at 10,803, up 0.6%.
The oil price relief rally is tempered somewhat by the expectation that this is just the latest likely temporary holding position for the world's politics and energy complex.
Brent crude was below $91 a barrel, following the news that the US had paused its exchange of strikes with Iran over the weekend.
09:51 — Brent's 10% Iran-pause slide anchors equities
As London's FTSE 100 holds onto the morning's gains, up 0.78%, at 10,821, the session's real driver remains the oil market where the ebb in hostilities between Donald Trump's America and Iran mean risk premiums have again receded.
Brent crude has dropped roughly 10% to trade near $86 a barrel following news that the US and Iran have agreed a pause in the conflict, a move that has compressed the geopolitical risk premium built into crude through recent weeks.
Patrick Munnelly, analyst at Tickmill, cautions the move is "a relief rally, not a resolution rally".
Brent's fall has freed up room for bonds and equities to recover and taken pressure off central banks, but Red Sea shipping risks remain live, and Hormuz traffic has not fully normalised.
09:01 — Airlines join advance as Vodafone holds 3% gain
International Consolidated Airlines Group was among the leaders in the FTSE 100, supported by lower fuels, amidst what's still a temporary swing in the geopolitical story for the Middle East.
The British Airways owner was up 4.19% to 452.4p on Monday.
Elsewhere, Vodafone (LSE:VOD) continues to hold its gain at 3.02% to 118.06p, still the clearest read-through from this morning's corporate news to the share price. The company's Q1 trading update points to organic service revenue up 5.2% and adjusted EBITDAaL growth of 6.2%, with management describing broad-based growth across Germany, the UK and Africa.
The oil-linked stocks remain on the backfoot, the counterweight to the morning's sentiments.
Harbour Energy (LSE:HBR) shares are down 4.84% to 243.8p, still tracking Brent's retreat toward $87 a barrel.
08:21 — FTSE 100 start on the front foot, whilst oil stocks slide
The FTSE 100 began the week on the front foot, up 0.78%, at 10,821.3.
Oil-linked names are absorbing the weekend's crude slump. Harbour Energy (LSE:HBR) shares dropped 5.25% to 242.76p, and Ithaca Energy (LSE:ITH) fell 3.72% to 248p, to sit at its session low.
Brent's crude was 6.65% lower on the day, extending the prior slide.
Looking back to London,
Vodafone (LSE:VOD) shares were up 4.28% trading at 119.5p on Monday morning's guidance upgrade.
Whilst AstraZeneca (LSE:AZN)'s shares climbed 1.86%, changing hands at 12,904 on the morning it released financials, and two separate, mixed trial updates - Sone-Ve's gastric cancer trial success against Ultomiris' trial miss, have yet to show up among the market's biggest movers this morning.
08:11 — Deal terms emerge on DCC Energy and Pharos as Serica gatecrashes bid
The morning's takeover situations are in focus, Private equity's swoop on DCC Energy is now confirmed as a roughly £5.75bn deal, with Dragon Bidco, the vehicle backed by Energy Capital Partners and KKR, recommended under Irish takeover rules.
Serica Energy (AIM:SQZ)'s move on Pharos has also crystallised into a number: Serica has tabled a £145.7m offer for Pharos, gatecrashing a rival bid from Ratio.
Vodafone (LSE:VOD)'s Q1 update carries a guidance angle beyond the headline growth figures already reported, the company says it is updating guidance following completion of the Safaricom transaction, with FY27 guidance lifted to the upper end after the strong first quarter.
Elsewhere, Integrated Diagnostics Holdings (LSE:IDHC) has published a Day 16 acceptance level update on Hena Holdings' unrecommended mandatory final cash offer, a situation that continues to run in parallel to London's bigger takeover stories.
07:31 — AstraZeneca, Vodafone and two takeovers headline London's morning newsflow
London's corporate calendar delivers its first substantial wave of the day, with AstraZeneca reporting first-half results built on double-digit growth in Oncology and Rare Disease, which offset the ongoing hit from Farxiga's US loss of exclusivity and China's volume-based procurement scheme. Total revenue rose 6% at constant exchange rates, core operating profit and core EPS both increased 11%, and the board lifted the interim dividend by 3 cents to $1.06 per share. Chief executive Pascal Soriot's group says it remains on track for its 2030 ambition of $80 billion in total revenue, with 30 regulatory approvals secured since the fourth-quarter results.
Vodafone (LSE:VOD)'s first-quarter trading update points to organic service revenue growth of 5.2%, with the group citing broad-based momentum across Germany, the UK and its African operations, the latter growing at a double-digit organic pace. Organic adjusted EBITDAaL rose 6.2%, helped by the new phase of cost initiatives announced in May, and the group says it is updating guidance following completion of the Safaricom transaction.
Two recommended takeovers add an M&A dimension to the morning. Serica Energy (AIM:SQZ) has agreed a recommended acquisition of Pharos Energy, while DCC Energy (LSE:DCC) is the target of a recommended bid from Dragon Bidco, a vehicle backed by funds advised by Energy Capital Partners Management and Kohlberg Kravis Roberts, under Irish takeover rules.
Elsewhere, Vesuvius (LSE:VSVS) and Shearwater Group (AIM:SWG) have both issued trading updates, while Everyman Media reports revenue up 24% as the cinema group weighs delisting and Aston Martin has moved to clarify its debt collateral structure. The newsflow lands with FTSE 100 futures still pointing sharply higher, indicated around 10,798, as Brent crude's sharp reversal continues to shape the backdrop into the cash open.
06:45 — FTSE set to open at record highs as oil slumps 5% on Iran ceasefire
London heads into Monday's session primed for a firm open, with the FTSE 100 indicated at 10,772.7 on out-of-hours pricing, up 0.33% and building on Friday's close of 10,731.66. European futures point the same way, with the DAX having closed Friday's session up 0.87% at 24,979.15.
Wall Street's Friday finish was split down the middle. The Dow added 0.44% to 51,939.9, the S&P 500 was essentially flat at 7,406.63, and the Nasdaq Composite lagged with a 0.71% decline to 24,960.115, weighed by softness in chip stocks. Out-of-hours indications for Monday point to a considerably stronger US reopen, with the S&P pricing up 0.9%, the Dow up 0.76% and the Nasdaq 100 indicated 1.48% firmer. Asia's session added to the constructive tone, with the Nikkei 225 up 0.22% to 64,754.19.
The standout overnight move is in crude. Brent is indicated down 5.37% at $87.40 and WTI down 5.68% at $83.62, both sharp reversals tied to reported easing in the US-Iran conflict and ceasefire expectations. That drop in energy costs, alongside a softer dollar, the DXY down 0.28% to 101.185, has helped lift gold 0.49% to $4,090.7. Cable is firmer too, with GBP/USD indicated up 0.23% at 1.3354. Bitcoin is little changed at $65,329, while the VIX sits at 18.71, showing no sign of stress heading into a week that brings central bank decisions from the Fed, Bank of Japan and Bank of England alongside a fresh round of Magnificent Seven earnings.
